AMRI buys Hyaluron to enter prefilled syringes market
June 21, 2010Manufacturing and Production AMRI, Hyaluron
Contract manufacturing organisation Albany Molecular Research Inc (AMRI) has added to its capabilities with the $27 million purchase of US …
NICE rejects Yondelis in ovarian cancer
June 21, 2010Sales and Marketing NICE, PharmaMar, Yondelis, ovarian cancer
New cancer treatment Yondelis has been rejected by NICE in a preliminary ruling on its use in relapsed ovarian cancer. …
Avastin will remain gold standard for lung cancer to 2018
June 20, 2010Decision Resources, NSCLC, Roche drug tipped to remain key to treatment, avastin
Industry analysts Decision Resources believes that Roche’s Avastin plus chemotherapy agents will remain as the gold standard for the treatment …
Digital Pharma: Byte-sized roundup
June 18, 2010Medical Communications, Research and Development FDA, Genzyme, NHS, Pfizer, digital pharma med coms, digital pharma research, social media
This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media …
Fishawack acquires Alpha-Plus
June 18, 2010Medical Communications fishawack
Fishawack has acquired fellow medical communications agency Alpha-Plus as it continues its ‘buy and build’ expansion plan. This has recently …
Contract research news in brief
June 18, 2010Research and Development CRO, ClinStar, Covance, ICON, Parexel, Phlexglobal, Quintiles, chiltern, contract research
Good news abounds in the CRO sector at the moment, with a raft of business expansions, investments, and new contracts …
Prolia gets early thumbs up from NICE
June 18, 2010Sales and Marketing Amgen, NICE, Prolia
Amgen’s new treatment to prevent bone fractures caused by osteoporosis has been given preliminary approval from the UK’s cost effectiveness …
J&J expands recall of ‘musty’ products
June 18, 2010Manufacturing and Production Johnson & Johnson, manufacturing compliance
Johnson & Johnson’s manufacturing troubles continues to build with yet another recall announced this week, this time for additional lots …
MedImmune Ventures appoints Ron Laufer
June 18, 2010Research and Development AstraZeneca, MedImmune, appointment, research and development
Ron Laufer has joined MedImmune’s venture capital arm as senior managing director. The company, which is the worldwide biologics unit …
Bayer signs cancer stem cell research deal
June 18, 2010Research and Development Bayer Schering Pharma, Cancer, OncoMed, Stem cells
Bayer Schering Pharma has teamed up with a US oncology specialist to develop novel antibodies, protein therapeutics and small molecules …
Kemwell expands Swedish production unit
June 17, 2010Manufacturing and Production Kemwell, contract manufacturing
Indian contract manufacturer Kemwell has doubled production capacity at its facility in Sweden in order to help it serve customers …
Trials of cancer vaccine Stimuvax can resume
June 17, 2010Research and Development Merck Serono, Stimuvax, cancer vaccine, vaccines
Merck Serono has been given clearance to resume part of its clinical trials of its cancer vaccine Stimuvax. Trials of …
UCB’s new lupus treatment promising
June 17, 2010Research and Development Benlysta, Lupus, UCB, epratuzumab
A new monoclonal antibody treatment for lupus has shown promise in phase II trials, according to UCB. The biopharmaceutical company …
PAN makes creative appointments
June 17, 2010Medical Communications Pan, appointment, medical communications
UK agency PAN Advertising has made two new appointments to its creative department – Gareth Goh as copywriter and Adam Wood as …
ABPI appoints former AZ innovation head
June 17, 2010Research and Development, Sales and Marketing ABPI, appointment, research and development, sales and marketing
UK industry association the ABPI has appointed Carol Blount as its new head of commercial affairs. Carol has more than …
Reinventing Management
June 17, 2010Research and Development, Sales and Marketing management
The investment banking industry officially ceased to exist on September 21, 2008. That was the day the last two remaining …
NICE rejects Tarceva maintenance treatment
June 17, 2010Sales and Marketing NICE, NSCLC, Roche, Tarceva, lung cancer
Roche’s Tarceva should not be used in lung cancer patients who have already been treated and whose disease remains stable, …
Digital Pharma: Amgen’s online village
June 16, 2010Medical Communications Amgen, ITP, community, disease awareness campaigns
Amgen has launched an online community for European healthcare professionals, patients and carers affected by autoimmune disease immune thrombycytopenia. Styled …
FDA to make safety reviews public
June 16, 2010Research and Development, Sales and Marketing FDA, drug safety
The US medicines regulator is to make safety reviews of recently approved prescription medicines more readily available to the public. …
Former FDA and MHRA regulators join Parexel Consulting
June 16, 2010Research and Development CRO, Parexel, appointment, research and development
Parexel Consulting has appointed former regulators Toby Silverman, M.D. and Keith Watson, Ph.D. as principal consultants. The company is a …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
